Annual Total Long Term Liabilities
$40.33 M
+$37.81 M+1501.51%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual total long term liabilities is $40.33 million, with the most recent change of +$37.81 million (+1501.51%) on December 31, 2023.
- During the last 3 years, ERNA annual total long term liabilities has risen by +$38.20 million (+1800.38%).
- ERNA annual total long term liabilities is now at all-time high.
Performance
ERNA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$43.16 M
-$2.25 M-4.96%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly total long term liabilities is $43.16 million, with the most recent change of -$2.25 million (-4.96%) on September 30, 2024.
- Over the past year, ERNA quarterly long term liabilities has increased by +$2.83 million (+7.03%).
- ERNA quarterly long term liabilities is now -4.96% below its all-time high of $45.41 million, reached on June 30, 2024.
Performance
ERNA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ERNA Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1501.5% | +7.0% |
3 y3 years | +1800.4% | +1758.7% |
5 y5 years | +1800.4% | +1758.7% |
ERNA Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1620.4% | -5.0% | +1758.7% |
5 y | 5-year | at high | +1800.4% | -5.0% | +1933.9% |
alltime | all time | at high | +1800.4% | -5.0% | +1933.9% |
Eterna Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $43.16 M(-5.0%) |
Jun 2024 | - | $45.41 M(+0.2%) |
Mar 2024 | - | $45.30 M(+12.3%) |
Dec 2023 | $40.33 M(+1501.5%) | $40.33 M(+3.2%) |
Sep 2023 | - | $39.06 M(+8.7%) |
Jun 2023 | - | $35.92 M(+1447.1%) |
Mar 2023 | - | $2.32 M(-7.8%) |
Dec 2022 | $2.52 M | $2.52 M(-45.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $4.65 M(-7.2%) |
Jun 2022 | - | $5.00 M(-65.2%) |
Mar 2022 | - | $14.38 M(+513.5%) |
Dec 2021 | $2.34 M(+10.5%) | - |
Dec 2021 | - | $2.34 M(-89.2%) |
Sep 2021 | - | $21.79 M(-0.2%) |
Jun 2021 | - | $21.84 M(+2.9%) |
Mar 2021 | - | $21.22 M(+899.9%) |
Dec 2020 | $2.12 M | $2.12 M |
FAQ
- What is Eterna Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Eterna Therapeutics?
- What is Eterna Therapeutics annual total long term liabilities year-on-year change?
- What is Eterna Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly long term liabilities year-on-year change?
What is Eterna Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ERNA is $40.33 M
What is the all time high annual total long term liabilities for Eterna Therapeutics?
Eterna Therapeutics all-time high annual total long term liabilities is $40.33 M
What is Eterna Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ERNA annual total long term liabilities has changed by +$37.81 M (+1501.51%)
What is Eterna Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ERNA is $43.16 M
What is the all time high quarterly long term liabilities for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly total long term liabilities is $45.41 M
What is Eterna Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ERNA quarterly total long term liabilities has changed by +$2.83 M (+7.03%)